Conference Proceedings
Disability Improvement Is Observed in Each Functional System in Alemtuzumab-Treated Patients With Active RRMS: Results From CARE-MS II Extension
Samuel F Hunter, Rany A Aburashed, Raed Alroughani, Steven M Bromley, Dominique Dive, Guillermo Izquierdo, Ho Jin Kim, Jan Lycke, Richard AL Macdonell, Carlo Pozzilli, Basil Sharrack, Patrick Vermersch, Andreas Lysandropoulos, Luke Chung, Nadia Daizadeh, Heinz Wiendl
NEUROLOGY | LIPPINCOTT WILLIAMS & WILKINS | Published : 2018
Grants
Funding Acknowledgements
Study Supported by: Sanofi and Bayer Healthcare Pharmaceuticals